Imatinib is a medicine used in the management of certain oncology conditions. By inhibiting specific protein kinases, this agent slows the progression of malignant cellular growth.
Managing certain types of blood and bone marrow cancers often involves using specialized medicine to target abnormal cells. Imatinib acts as a protein tyrosine kinase inhibitor, which is a type of medicine that interferes with the chemical signals cancer cells need to grow and multiply. It serves as the active compound in various products, including the medication known as Gleevec.
This targeted therapy helps control the progression of specific conditions by changing how your body responds to cancerous cell signals. By blocking the activity of these specific proteins, it limits the reproduction of cells that drive these illnesses. It does not fix your DNA but instead works to alter the environment that allows these cells to thrive.
Addressing chronic myeloid leukaemia (CML) remains a primary role for this medicine. It also manages specific cases of acute lymphoblastic leukaemia where the cells show a particular genetic change. Doctors may coordinate its use for gastrointestinal stromal tumours (GIST) or myelodysplastic syndrome.
People living with these conditions often manage them long-term with this therapy. It supports the reduction of abnormal blood cell levels in your body. Your healthcare team determines if this approach fits your unique situation based on blood tests and genetic assessments.
Cancer cells often rely on faulty protein signals to receive instructions for rapid growth. This ingredient binds to those proteins, effectively shutting down the message sent to the cell. Without this signal, the abnormal cells stop dividing and often die off.
Think of it as placing an obstacle in a communication path. Your healthy cells remain largely unaffected because they do not rely on these specific faulty signals. By targeting the source of the growth, it helps keep your blood cell levels near a typical range.
Discuss your full health history with your team, especially if you have liver or heart concerns. Women should avoid this medicine during pregnancy due to the risk of fetal harm. You must also notify your team about other supplements, herbal remedies, or medicines you take, as these can alter how your body handles the treatment.
Grapefruit or grapefruit juice may change the levels of this medicine in your blood. Avoid these while on this therapy to maintain
